AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26729895 — intervention group
Group type: EXPERIMENTAL
Intervention: Rd
Number of subjects: 662
Study 24697402 — intervention group
Group type: EXPERIMENTAL
Intervention: More appropriate prosthesis
Number of subjects: 28
Study 24697402 — intervention group
Group type: COMPARATOR
Intervention: Less appropriate prosthesis
Number of subjects: 28
Study 24697402 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosthetic ankle
Number of subjects: 28
Study 24697402 — intervention group
Group type: EXPERIMENTAL
Intervention: Sound ankle
Number of subjects: 28
Study 22147365 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 1886
Study 22147365 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking and water pipe smoking
Number of subjects: 1886
Study 22147365 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental tobacco smoke exposure
Number of subjects: 1886
Study 22147365 — intervention group
Group type: EXPERIMENTAL
Intervention: History of schistosomiasis
Number of subjects: 1886
Study 20558918 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cephazolin (CEZ) at 2 g/day for 5 days
Number of subjects: 129
Study 20558918 — intervention group
Group type: COMPARATOR
Intervention: Oral levofloxacin (LVFX) at 300 mg/day for 5 days
Number of subjects: 129
Study 18028054 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine/thymol (CHX/T) varnish
Number of subjects: 0
Study 18028054 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride (F) varnish
Number of subjects: 0
Study 18028054 — intervention group
Group type: COMPARATOR
Intervention: Control (uncoated discs)
Number of subjects: 0
Study 18028054 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine/thymol (CHX/T) varnish (non-immersed)
Number of subjects: 0
Study 16200264 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotablator
Number of subjects: 22
Study 16200264 — intervention group
Group type: COMPARATOR
Intervention: Balloon angioplasty
Number of subjects: 22
Study 12377852 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 266
Study 12377852 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime with or without erythromycin
Number of subjects: 266
Study 9916954 — intervention group
Group type: EXPERIMENTAL
Intervention: Early oral feeding
Number of subjects: 61
Study 9916954 — intervention group
Group type: COMPARATOR
Intervention: Nasogastric decompression
Number of subjects: 61
Study 7561823 — intervention group
Group type: EXPERIMENTAL
Intervention: Active medication (anticholinergic agents)
Number of subjects: 0
Study 7561823 — intervention group
Group type: COMPARATOR
Intervention: Placebo medication
Number of subjects: 0
Study 7561823 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses' guesses
Number of subjects: 0
Study 1973718 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 4 g every 24 hours for 5 to 7 days
Number of subjects: 92
Study 1973718 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 2 g every 12 hours for 5 to 7 days
Number of subjects: 92
Study 1973718 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone 2 g every 24 hours for 5 to 7 days
Number of subjects: 92
Study 1973718 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course treatment regimens (any of the above)
Number of subjects: 92
Study 6112444 — intervention group
Group type: EXPERIMENTAL
Intervention: Traction
Number of subjects: 322
Study 6112444 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercises
Number of subjects: 322
Study 6112444 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation
Number of subjects: 322
Study 6112444 — intervention group
Group type: EXPERIMENTAL
Intervention: Corset
Number of subjects: 322
Study 6112444 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of treatments
Number of subjects: 322
Study 31348316 — intervention group
Group type: EXPERIMENTAL
Intervention: Pit and fissure sealants
Number of subjects: 228
Study 31348316 — intervention group
Group type: COMPARATOR
Intervention: Fluoride varnish
Number of subjects: 228
Study 29664873 — intervention group
Group type: EXPERIMENTAL
Intervention: De-escalation pathway
Number of subjects: 246
Study 26577936 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate 2% and chondroitin sulfate 2% (Arthrum HCS®)
Number of subjects: 112
Study 24934429 — intervention group
Group type: EXPERIMENTAL
Intervention: Stretching
Number of subjects: 30
Study 24934429 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic movement
Number of subjects: 30
Study 24934429 — intervention group
Group type: COMPARATOR
Intervention: Reference group (no specific intervention mentioned)
Number of subjects: 30
Study 24934429 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions (stretching, dynamic movement, reference)
Number of subjects: 30
Study 22670550 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% oxygen dive
Number of subjects: 11
Study 22670550 — intervention group
Group type: COMPARATOR
Intervention: Air dive
Number of subjects: 11
Study 20153482 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS (1800 stimuli at just below active motor threshold intensity, 1Hz for four consecutive days)
Number of subjects: 10
Study 20153482 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS (placebo)
Number of subjects: 10
Study 17356507 — intervention group
Group type: EXPERIMENTAL
Intervention: mepivacaine + ropivacaine 40 mg
Number of subjects: 30
Study 17356507 — intervention group
Group type: EXPERIMENTAL
Intervention: mepivacaine + ropivacaine 25 mg
Number of subjects: 30
Study 17356507 — intervention group
Group type: COMPARATOR
Intervention: mepivacaine 1.5% (300 mg)
Number of subjects: 30
Study 16356430 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial L-thyroxine dose of 50 mug
Number of subjects: 31
Study 16356430 — intervention group
Group type: COMPARATOR
Intervention: Initial L-thyroxine doses (50 mug, 37.5 mug)
Number of subjects: 31
Study 16356430 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate congenital hypothyroidism
Number of subjects: 31
Study 16356430 — intervention group
Group type: EXPERIMENTAL
Intervention: Time to normalize thyroid function > 2 weeks
Number of subjects: 31
Study 12190674 — intervention group
Group type: EXPERIMENTAL
Intervention: Live Lactobacillus plantarum 299 with oat fibre
Number of subjects: 45
Study 12190674 — intervention group
Group type: COMPARATOR
Intervention: Heat-killed Lactobacillus plantarum 299 with oat fibre
Number of subjects: 45
Study 9523807 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS (bispectral index) and sevoflurane concentration
Number of subjects: 69
Study 9523807 — intervention group
Group type: EXPERIMENTAL
Intervention: 95% SEF (spectral edge frequency)
Number of subjects: 69
Study 9523807 — intervention group
Group type: EXPERIMENTAL
Intervention: MPF (median power frequency)
Number of subjects: 69
Study 9523807 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane concentration
Number of subjects: 69
Study 9523807 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG parameters
Number of subjects: 69
Study 7648821 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-h daytime urine specimen collection
Number of subjects: 922
Study 7648821 — intervention group
Group type: COMPARATOR
Intervention: Timed overnight urine collection
Number of subjects: 922
Study 7648821 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary albumin excretion rate (UAE)
Number of subjects: 922
Study 7648821 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary albumin creatinine ratio (UACR)
Number of subjects: 922
Study 7648821 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary albumin concentration (UAC)
Number of subjects: 922
Study 2652018 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 44
Study 2652018 — intervention group
Group type: COMPARATOR
Intervention: Prochlorperazine
Number of subjects: 44
Study 328880 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (150-300 mg daily)
Number of subjects: 102
Study 328880 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (1200-2400 mg daily)
Number of subjects: 102
Study 31712348 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive skin surveillance programme consisting of 3D total-body photography, sequential digital dermoscopy, and melanoma-risk stratification.
Number of subjects: 0
Study 31712348 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical care (control)
Number of subjects: 0
Study 31712348 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive skin surveillance programme
Number of subjects: 0
Study 28206732 — intervention group
Group type: EXPERIMENTAL
Intervention: MPFF 1000-mg oral suspension once daily
Number of subjects: 1139
Study 28206732 — intervention group
Group type: COMPARATOR
Intervention: MPFF 500-mg tablets twice daily
Number of subjects: 1139
Study 25494972 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium-induced hyperhydration (SIH)
Number of subjects: 17
Study 25494972 — intervention group
Group type: COMPARATOR
Intervention: Glycerol-induced hyperhydration (GIH)
Number of subjects: 17
Study 25494972 — intervention group
Group type: COMPARATOR
Intervention: Water-induced hyperhydration (WIH)
Number of subjects: 17
Study 24063913 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-eluting stents (DES)
Number of subjects: 2314
Study 24063913 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 2314
Study 21702670 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-step composite finishing/polishing disc system (Enhance Flex NST-EF)
Number of subjects: 75
Study 21702670 — intervention group
Group type: COMPARATOR
Intervention: Four-step composite finishing/polishing disc system (Sof-Lex-SL)
Number of subjects: 75
Study 21702670 — intervention group
Group type: COMPARATOR
Intervention: Four-step composite finishing/polishing disc system (Super-Snap-SS)
Number of subjects: 75
Study 19336514 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled GH
Number of subjects: 22
Study 19336514 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous GH (sc GH)
Number of subjects: 22
Study 19336514 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled GH and sc GH
Number of subjects: 22
Study 16672024 — intervention group
Group type: EXPERIMENTAL
Intervention: Resorbable screws made of poly (D.L‐lactide) acid (PDLLA)
Number of subjects: 8
Study 16672024 — intervention group
Group type: COMPARATOR
Intervention: Titanium screws
Number of subjects: 8
Study 15475033 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged Garlic Extract (AGE) 4 ml
Number of subjects: 19
Study 15475033 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 15475033 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged Garlic Extract (AGE)
Number of subjects: 19
Study 11533101 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34-selected PBPCs
Number of subjects: 190
Study 11533101 — intervention group
Group type: COMPARATOR
Intervention: Unselected PBPCs
Number of subjects: 190
Study 11299622 — intervention group
Group type: EXPERIMENTAL
Intervention: PROLENE hernia system (PHS) double mesh grafts
Number of subjects: 10
Study 8778709 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive exercise protocol on a treadmill
Number of subjects: 17
Study 1839436 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (once daily)
Number of subjects: 0
Study 1839436 — intervention group
Group type: COMPARATOR
Intervention: Captopril (twice daily)
Number of subjects: 0
Study 6223583 — intervention group
Group type: EXPERIMENTAL
Intervention: SPG (20 mg twice a week or 40 mg once a week) in combination with tegafur
Number of subjects: 190
Study 6223583 — intervention group
Group type: COMPARATOR
Intervention: Tegafur (control group)
Number of subjects: 190
Study 6223583 — intervention group
Group type: EXPERIMENTAL
Intervention: SPG (20 mg twice a week or 40 mg once a week)
Number of subjects: 190
Study 31823475 — intervention group
Group type: EXPERIMENTAL
Intervention: Category A (sheath removed upon return to recovery without activated clotting time (ACT))
Number of subjects: 152
Study 31823475 — intervention group
Group type: EXPERIMENTAL
Intervention: Category C (ACT check 1‐h postheparin and sheath removed once ACT < 160)
Number of subjects: 152
Study 31823475 — intervention group
Group type: EXPERIMENTAL
Intervention: Category B (ACT check 1‐h postheparin and sheath removed without knowing the ACT)
Number of subjects: 152
Study 31823475 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but implied as no ACT measurement)
Number of subjects: 152
Study 27918841 — intervention group
Group type: EXPERIMENTAL
Intervention: summerMAX treatment (5-week program targeting social skills, nonliteral language skills, face-emotion recognition, interest expansion)
Number of subjects: 57
Study 27918841 — intervention group
Group type: EXPERIMENTAL
Intervention: summerMAX treatment
Number of subjects: 57
Study 27918841 — intervention group
Group type: COMPARATOR
Intervention: waitlist control
Number of subjects: 57
Study 29602860 — intervention group
Group type: EXPERIMENTAL
Intervention: Therabite
Number of subjects: 0
Study 29602860 — intervention group
Group type: COMPARATOR
Intervention: Wooden spatula
Number of subjects: 0
Study 27765029 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (resident-directed intervention)
Number of subjects: 112
Study 27765029 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 112
Study 25201615 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Lumbar Stabilization (DLS) exercises
Number of subjects: 44
Study 22883186 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial coronary intervention (TRI)
Number of subjects: 360
Study 22883186 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral intervention (TFI)
Number of subjects: 360
Study 19842002 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual source of healthcare (USHC)
Number of subjects: 3899
Study 19842002 — intervention group
Group type: COMPARATOR
Intervention: No usual source of healthcare (USHC)
Number of subjects: 3899
Study 17444308 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine plus 0.25 mg/kg ketamine
Number of subjects: 41
Study 17444308 — intervention group
Group type: COMPARATOR
Intervention: Morphine alone
Number of subjects: 41
Study 16042793 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention on malaria transmission and prevention
Number of subjects: 132
Study 16042793 — intervention group
Group type: COMPARATOR
Intervention: No educational intervention (Control)
Number of subjects: 132
Study 12411833 — intervention group
Group type: COMPARATOR
Intervention: Cerebral perfusion volume in controls
Number of subjects: 50
Study 12411833 — intervention group
Group type: COMPARATOR
Intervention: Volume loss index (VLI) corrected for age and sex
Number of subjects: 50
Study 12411833 — intervention group
Group type: COMPARATOR
Intervention: Percentage uptake of HMPAO
Number of subjects: 50
Study 12411833 — intervention group
Group type: COMPARATOR
Intervention: Repeatability coefficient for controls
Number of subjects: 50
Study 9696475 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin treatment
Number of subjects: 26
Study 9696475 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 26
Study 7671174 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative cardiovascular clinical trials
Number of subjects: 0
Study 7671174 — intervention group
Group type: EXPERIMENTAL
Intervention: Canadian Cardiovascular Collaboration (CCC)
Number of subjects: 0
Study 2782361 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydration (5% dextrose in lactated Ringer's solution, intravenous bolus and continuous infusion)
Number of subjects: 48
Study 2782361 — intervention group
Group type: COMPARATOR
Intervention: Bed rest alone (control group)
Number of subjects: 48
Study 31173127 — intervention group
Group type: EXPERIMENTAL
Intervention: High NUF rate (>1.75 mL/kg/h)
Number of subjects: 1434
Study 31173127 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in NUF rate (every 0.5 mL/kg/h)
Number of subjects: 1434
Study 28651403 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily group
Number of subjects: 328
Study 28651403 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent group
Number of subjects: 328
Study 28651403 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 328
Study 28651403 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between daily and intermittent groups
Number of subjects: 328
Study 26218785 — intervention group
Group type: EXPERIMENTAL
Intervention: acu‐TENS group (n=25)
Number of subjects: 50
Study 26218785 — intervention group
Group type: COMPARATOR
Intervention: placebo acu‐TENS control group (n=25)
Number of subjects: 50
Study 23714287 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive care and support from a case manager (UP group)
Number of subjects: 450
Study 23714287 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive care and support from a case manager plus a technological toolkit (UP-TECH group)
Number of subjects: 450
Study 23714287 — intervention group
Group type: COMPARATOR
Intervention: Brochures regarding available services (Control group)
Number of subjects: 450
Study 21617516 — intervention group
Group type: EXPERIMENTAL
Intervention: Gross prosections
Number of subjects: 0
Study 21617516 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-dimensional stereoscopic computer model
Number of subjects: 0
Study 21617516 — intervention group
Group type: EXPERIMENTAL
Intervention: Both resources (gross prosections and 3D models)
Number of subjects: 0
Study 19148765 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively oriented Behavioral Rehabilitation (CBR) and Qigong
Number of subjects: 136
Study 19148765 — intervention group
Group type: COMPARATOR
Intervention: Qigong only
Number of subjects: 136
Study 16297472 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate, ketogenic diet (LCKD) with nutritional supplementation (including fish, borage and flaxseed oil)
Number of subjects: 119
Study 16297472 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate, ketogenic diet (LCKD)
Number of subjects: 119
Study 16297472 — intervention group
Group type: COMPARATOR
Intervention: Low-fat, reduced-calorie diet (LFD)
Number of subjects: 119
Study 15317700 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (15 mg/kg) half an hour before surgery
Number of subjects: 40
Study 15317700 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisolone (0.5 mg/kg) for 2 weeks, tapered postoperatively
Number of subjects: 40
Study 15317700 — intervention group
Group type: COMPARATOR
Intervention: Both groups (Intravenous methylprednisolone and Oral prednisolone)
Number of subjects: 40
Study 11287372 — intervention group
Group type: EXPERIMENTAL
Intervention: Tremor presence and severity in patients with multiple sclerosis
Number of subjects: 100
Study 11287372 — intervention group
Group type: EXPERIMENTAL
Intervention: Tremor-related disability
Number of subjects: 100
Study 11287372 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of tremor severity with clinical features
Number of subjects: 100
Study 11287372 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of patients with and without tremor
Number of subjects: 100
Study 9071936 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g coarse bran
Number of subjects: 13
Study 9071936 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g inert plastic particles
Number of subjects: 13
Study 9071936 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 g ispaghula
Number of subjects: 13
Study 9071936 — intervention group
Group type: COMPARATOR
Intervention: Control values
Number of subjects: 13
Study 8306006 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (individualized feedback and preceptor guidance)
Number of subjects: 311
Study 8306006 — intervention group
Group type: COMPARATOR
Intervention: Control group (no further intervention)
Number of subjects: 311
Study 8306006 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 311
Study 8306006 — intervention group
Group type: COMPARATOR
Intervention: Librarian searches
Number of subjects: 311
Study 2881183 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12
Study 2881183 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol + Nifedipine
Number of subjects: 12
Study 2881183 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 12
Study 2881183 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 12
Study 2881183 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol + Nifedipine
Number of subjects: 12
Study 2881183 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker
Number of subjects: 12
Study 2881183 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Beta-blockade + Nifedipine)
Number of subjects: 12
Study 30958141 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress reduction intervention (5-weekly sessions)
Number of subjects: 54
Study 30958141 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 54
Study 29551546 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention programme (listening to traditional music and playing musical instruments) three times a week for twelve weeks
Number of subjects: 77
Study 29551546 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music intervention)
Number of subjects: 77
Study 29551546 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention programme
Number of subjects: 77
Study 27181070 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 U/kg IDegAsp
Number of subjects: 21
Study 27181070 — intervention group
Group type: COMPARATOR
Intervention: biphasic insulin aspart 30
Number of subjects: 21
Study 25919069 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric Bypass (GB)
Number of subjects: 50
Study 25919069 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG)
Number of subjects: 50
Study 23848405 — intervention group
Group type: COMPARATOR
Intervention: 1 μg.kg(‐1) intranasal dexmedetomidine with 3 mg.kg(‐1) oral ketamine (Group 1)
Number of subjects: 160
Study 23848405 — intervention group
Group type: COMPARATOR
Intervention: 1 μg.kg(‐1) intranasal dexmedetomidine with 5 mg.kg(‐1) oral ketamine (Group 2)
Number of subjects: 160
Study 23848405 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 μg.kg(‐1) intranasal dexmedetomidine with 3 mg.kg(‐1) oral ketamine (Group 3)
Number of subjects: 160